Analgesic Efficacy of Saphenous Nerve Block in Total Knee Replacement
Post Operative Pain
About this trial
This is an interventional treatment trial for Post Operative Pain focused on measuring Total Knee Replacement, Bupivacaine, Levobupivacaine, Saphenous Nerve Block, Local Infiltration Analgesia
Eligibility Criteria
Inclusion Criteria:
American Society of Anaesthesia (ASA) Grade I-lll patients Undergoing elective Total Knee Arthroplasty Patients able to consent and understand all the components of the study.
Exclusion Criteria:
Demented patients Patients having bilateral Knee Replacements Patients unable to comprehend the use of pain scales Allergy to any of the medications used in the study Renal dysfunction Coagulation disorders Peptic ulcer disease precluding use of non-steroidal anti-inflammatory drugs (NSAIDs) Patients unable to use regular opioid medication Any chronic pain condition other than osteoarthritis of the knee.
Sites / Locations
- Dept. of Anaesthesia & Intensive Care Unit, Cork University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
SNB Saphenous Nerve block
NSNB Non Saphenous Nerve Block
Patients received SNB preoperatively at mid thigh level with ultrasound guidance. 10 mls 0.5% bupivacaine was administered for nerve block by the anesthetist. All patients also received peri operative Local Infiltration Analgesia by the surgeon. All patients will receive preoperative oxycontin, peri operative paracetamol and diclofenac. Post operatively all patients received regular paracetamol 1g 6 hourly, Diclofenac sodium 12 hourly and oxycontin 10-20 mg 12 hourly. All patients received standardized spinal block by the same anesthetist, post nerve block for surgery.
Patients only received Local Infiltration Analgesia. As per protocol all patients received the same pre, peri and post operative analgesia as described in the experimental group. All patients had a standardized spinal block for surgery.